P&T Committee Changes
October 5, 2023Primary Formulary Step Therapy
October 5, 2023Specialty medications are medications that require special handling, personalized care, monitoring, or special delivery needs. These products, whether injectable or non‐injectable medications, require specialized clinical management, patient education and training, as well as specific packing, handling, and shipping requirements. Specialty medications include treatments used in disease states such as arthritis, hepatitis, multiple sclerosis, oncology, and other therapies where compliance plays a key factor in treatment goals and outcomes.
| Therapeutic Category | Drug Name | Route of Administration | Limited Distribution / Biosimilars |
|---|---|---|---|
| Allergy / Respiratory Allergen Immunotherapy | |||
| Grastek | Sublingual | ||
| Odactra | Sublingual | ||
| Oralair | Sublingual | ||
| Palforzia | Oral | ||
| Ragwitek | Sublingual | ||
| Alzheimer's Disease | |||
| Aduhelm | IV | ||
| Leqembi | IV | ||
| Asthma | |||
| Cinqair | IV | ||
| Fasenra | Injection (SQ) | ||
| Nucala | Injection (SQ) | LD | |
| Tezspire | Injection (SQ) | ||
| Xolair | Injection (SQ) | LD | |
| Cystic Fibrosis | |||
| Bethkis | Inhalation | LD | |
| Bronchitol | Inhalation | ||
| Orkambi | Oral | LD | |
| Pulmozyme | Inhalation | ||
| Tobi | Inhalation | LD | |
| Cayston | Inhalation | LD | |
| Symdeko | Oral | ||
| Trikafta | Oral | LD | |
| Kalydeco | Tablet | LD | |
| Idiopathic Pulmonary Fibrosis | |||
| Esbriet | Oral | LD | |
| Ofev | Oral | LD | |
| Malignant Hypertension | |||
| Vecamyl | Oral | ||
| Pulmonary Hypertension | |||
| Adcirca | Oral | ||
| Adempas | Oral | LD | |
| epoprostenol | IV | LD | |
| Flolan | IV | LD | |
| Letairis | Oral | LD | |
| Opsumit | Oral | LD | |
| Orenitram | Oral | LD | |
| Remodulin | Injection (SQ) or IV | LD | |
| Revatio | Oral | ||
| Tracleer | Oral | LD |